APUS
APIMEDS PHARM (APUS)
NYSE
$0.89$0.00 (0.00%)
Price as of Jun 23, 2026 5:01 PM EDT
  • $14.3M
    Market Cap
  • -94.34%
    1-Year Change
  • N/A
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
4.3M
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
4.3M
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-1.6M
N/A
N/A
N/A
Depreciation and Amortization Expense
5,706
N/A
N/A
N/A
Total Operating Expenses
11.9M
+834.25%
1.3M
N/A
Operating Profit
-11.9M
+834.25%
-1.3M
N/A
Interest Income
107,595
+3,710.02%
2,824
N/A
Interest Expense
N/A
N/A
-12,608
N/A
Interest Income and Expense and Net
107,595
+1,199.70%
-9,784
N/A
Total Nonoperating Income and Expense
5.9M
+5,245.07%
-114,895
N/A
Income before Taxes
-11.9M
+834.25%
-1.3M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-6.0M
+331.74%
-1.4M
N/A
Net Income from Continuing Operations Applicable to Common
-6.0M
+331.74%
-1.4M
N/A
Basic EPS and Net Income
-0.55
+205.56%
-0.18
N/A
Diluted EPS and Net Income
-0.55
+205.56%
-0.18
N/A
Basic Weighted Average Shares
10.9M
+37.68%
7.9M
N/A
Diluted Weighted Average Shares
10.9M
+37.68%
7.9M
N/A
Balance Sheet
Cash and Cash Equivalents
1.6M
+47,270.62%
3,455
N/A
Short-Term Investments
2.0M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.6M
+105,157.74%
3,455
N/A
Total Current Assets
14.0M
+106,998.56%
13,057
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
51,626
N/A
N/A
N/A
Total Long-Term Assets
51,626
N/A
N/A
N/A
Total Assets
164.2M
+1,257,338.43%
13,057
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
7.1M
+1,944.51%
346,844
N/A
Total Current Liabilities
10.7M
+945.21%
1.0M
N/A
Total Long-Term Debt
1.0M
N/A
N/A
N/A
Total Long-Term Liabilities
129,454
N/A
N/A
N/A
Total Liabilities
10.8M
+690.26%
1.4M
N/A
Retained Earnings
-10.4M
+136.64%
-4.4M
N/A
Total Stockholders Equity
153.3M
+11,391.18%
-1.4M
N/A
Total Shares Outstanding
12.6M
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-8.9M
+1,116.83%
-733,526
N/A
Capital Expenditures
57,333
N/A
N/A
N/A
Cash from Investing Activities
-10.1M
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
20.6M
+6,215.26%
326,500
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
-280.20%
N/A
N/A
N/A
Return on Assets
-7.31%
N/A
N/A
N/A
Return on Equity
-7.90%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
1.31
N/A
N/A
N/A
Cash Ratio
0.15
N/A
N/A
N/A
Debt-to-Equity Ratio
0.05
N/A
N/A
N/A
Debt-to-Assets Ratio
0.05
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow